Inhibition of prolyl hydroxylase activity and collagen biosynthesis by fibrostatin C, a novel inhibitor produced by Streptomyces catenulae subsp. griseospora No. 23924
- J Antibiot (Tokyo). 1988 Nov;41(11):1668-74. doi: 10.7164/antibiotics.41.1668.
- 1. Central Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan.
Fibrostatin C, a novel prolyl hydroxylase inhibitor produced by Streptomyces catenulae subsp. griseospora No. 23924, inhibited the activity of purified chick embryo prolyl hydroxylase by about 50% at a concentration of 2.9 x 10(-5) M. The inhibition was mixed type with respect to (Pro-Pro-Gly)5 with a Ki of 2.1 x 10(-5) M. When an excess of ferrous ions or ascorbate was added to the reaction mixture, the inhibition was negligibly or slightly reversed, respectively. Fibrostatin C, when administered intraperitoneally at 1 mg/kg/day or orally at about 100 mg/kg/day as a dietary admixture, significantly inhibited estradiol-17 beta stimulated Collagen biosynthesis in the uterus of the immature rat.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: HIF/HIF Prolyl-HydroxylaseResearch Areas: Others
-
target: HIF/HIF Prolyl-HydroxylaseResearch Areas: Metabolic Disease